Browsing Sydney Health Ethics by subject "1117 Public Health and Health Sciences"
-
Access to high cost cancer medicines through the lens of an Australian Senate Inquiry - defining the 'goods' at stake.
Published 2017-01-01In Australia, the government is the primary payer for cancer medicines, and is supported by the Pharmaceutical Benefits Advisory Committee, which makes recommendations about which medicines should be funded on the ...Open AccessArticle -
Applying the Theoretical Domains Framework to identify barriers and targeted interventions to enhance nurses’ use of electronic medication management systems in two Australian hospitals
Published 2017-01-01Background Medication errors harm hospitalised patients and increase health care costs. Electronic Medication Management Systems (EMMS) have been shown to reduce medication errors. However, nurses do not always use EMMS ...Article -
An archaeology of corruption in medicine.
Published 2014-01-01Corruption is a word used loosely to describe many kinds of action that people find dis-tasteful. We prefer to reserve it for the intentional misuse of the good offices of an established social entity for private benefit ...Open AccessArticle -
Caution needed in introduction of provisional approvals for medicines
Published 2017-01-01The Australian government recently released its response to the Review of Medicines and Medical Devices Regulation, accepting most recommendations. One recommendation involves the introduction of provisional approvals for ...Open AccessArticle -
Clarifying the relationship between serious ethical violations and conflicts of interest
Published 2019-01-01Open AccessArticle -
Clearing the air: towards agreement about access to high cost cancer medicines
Published 2018-01-01Oncologists have an important role to play in debates about access to high cost cancer medicines. But in order for oncologists to be able to fulfil this role they need to have a solid understanding of the contexts of debates ...Open AccessArticle -
Community views on factors influencing medicines resource allocation: a cross sectional survey of 3080 adults in Australia.
Published 2018-04-01Open AccessArticle -
Conflicted hope: social egg freezing and clinical conflicts of interest.
Published 2017-01-01Over the past decade ‘social egg freezing’ has emerged as a technology of hope that purports to empower women by enabling them to continue their careers or find the right partner without the fear of jeopardizing their ...Open AccessArticle -
Conflicts of Interest in Australia’s IVF Industry: an empirical analysis and call for action
Published 2017-01-01In Australia, the growing assisted reproductive technologies (ART) industry has recently received some public criticism. Much of this criticism centres on the concern that doctors are increasingly motivated by profit, ...Open AccessArticle -
Conflicts of interest in medicine: taking diversity seriously
Published 2017-01-01Background Conflicts of interest (COI) are considered ubiquitous in many healthcare arrangements (1) but there is disagreement on how COI should be defined, whether non-financial conflicts deserve attention, and the ...Open AccessArticle -
Debates about conflict of interest in medicine: Deconstructing a divided discourse.
Published 2017-01-01Rationale: The pharmaceutical industry plays an increasingly dominant role in health care, raising concerns about “conflicts of interest” (COI) on the part of the medical professionals who interact with the industry. These ...Open AccessArticle -
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.
Published 2018-01-01“Sunshine” policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, ...Open AccessArticle -
An ethical framework for the creation, governance and evaluation of accelerated access programs
Published 2018-09-01There are increasing demands on regulators and insurers internationally to provide access to medicines more quickly, and often on the basis of less robust evidence of safety, efficacy or cost-effectiveness than have ...Open AccessArticle -
Ethics and Epistemology in Big Data Research
Published 2017-01-01Biomedical innovation and translation are increasingly emphasizing research using “big data”. The hope is that big data methods will both speed up research and make its results more applicable to “real-world” patients and ...Open AccessArticle -
Formulating an Ethics of Pharmaceutical Disinvestment
Published 2020-03-03There is growing interest among pharmaceutical policymakers in how to “disinvest” from subsidised medicines. This is due to both the rapidly rising costs of healthcare and the increasing use of accelerated and conditional ...Open AccessArticle -
The global in global health is not a given.
Published 2017-01-01The process of globalization is commonly espoused as a means for promoting global health. Efforts to ‘go global’ can, however, easily go awry as a result of lack of attention to local social, economic and political contexts ...Open AccessArticle -
Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?
Published 2019-01-01Despite accumulating evidence indicating that paracetamol is no more efficacious than placebo for acute uncomplicated low back pain and symptomatic osteoarthritis, it is still prescribed for these conditions. This is likely ...Open AccessArticle -
Limiting religious contributions – a response to Schuklenk
Published 2019-01-29Open AccessArticle